Lin Xichen 4

4 · Structure Therapeutics Inc. · Filed Jun 5, 2024

Form 4

Period: 2024-06-03

CHIEF SCIENTIFIC OFFICER

Transactions

Sale
American Depositary Shares
2024-06-03$45.00/sh−17,700$796,500→ 17,700 total
→ Ordinary Shares (53,100 underlying)
Conversion
Ordinary Shares
2024-06-03−106,200→ 85,707 total
Sale
American Depositary Shares
2024-06-03$50.00/sh−17,700$885,071→ 0 total
→ Ordinary Shares (53,100 underlying)
Exercise/Conversion
Ordinary Shares
2024-06-03$0.34/sh+106,200$36,108→ 191,907 total
Exercise/Conversion
Share Option (right to buy)
2024-06-03−106,200→ 213,800 total
Exercise: $0.34Exp: 2029-09-10→ Ordinary Shares (106,200 underlying)
Conversion
American Depositary Shares
2024-06-03+35,400→ 35,400 total
→ Ordinary Shares (106,200 underlying)

Footnotes (7)

[F1]The Ordinary Shares were converted into American Depositary Shares as reported in Table II above.
[F2]1/4 of the shares vested one year after July 22, 2019 (the "Vesting Commencement Date"); the balance of the shares vested in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date.
[F3]This reflects the number of Ordinary Shares remaining under the share option following the partial exercise of the share option for 106,200 Ordinary Shares.
[F4]Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date.
[F5]106,200 Ordinary Shares, which were acquired upon exercise of a share option, were converted into 35,400 American Depositary Shares.
[F6]The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on December 28, 2023.
[F7]The weighted average sale price for the transaction reported was $50.004, and the range of prices were between $50.00 and $50.16. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.

Documents

1 file